title: Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
authors.affiliation: Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Aichi, Japan.
authors.forename: Michinori
authors.identifier: 0000000211527524
authors.initials: M
authors.lastname: Terada
authors.affiliation: Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Aichi, Japan.
authors.forename: Emiko
authors.initials: E
authors.lastname: Ohki
authors.affiliation: Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Aichi, Japan.
authors.forename: Yuka
authors.initials: Y
authors.lastname: Yamagishi
authors.affiliation: Teikyo University Institute of Medical Mycology, Tokyo, Japan.
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Nishiyama
authors.affiliation: Teikyo University Institute of Medical Mycology, Tokyo, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Satoh
authors.affiliation: Teikyo University Institute of Medical Mycology, Tokyo, Japan.
authors.forename: Katsuhisa
authors.initials: K
authors.lastname: Uchida
authors.affiliation: Teikyo University Institute of Medical Mycology, Tokyo, Japan.
authors.forename: Hideyo
authors.initials: H
authors.lastname: Yamaguchi
authors.affiliation: 1] Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Aichi, Japan [2] Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu, Japan.
authors.forename: Hiroshige
authors.initials: H
authors.lastname: Mikamo
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001203:Ascomycota / Q000187:drug effects* / Q000302:isolation & purification; D003928:Diabetic Nephropathies / Q000150:complications; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole; D014846:Vulvar Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D011743:Pyrimidines; D014230:Triazoles; D008525:Medroxyprogesterone; D065819:Voriconazole